The findings could provide potential targets for new Alzheimer’s drugs. By Leigh Hopper Researchers from a USC-led consortium have discovered “hotspots” in the genome that either speed ... Read More »
A transformative donation from the Epstein Family Foundation will accelerate Alzheimer’s research at the two universities in a push to find better treatments and a cure (Originally posted ... Read More »
Jeiran Choupan, PhD, MSCS, of the USC Mark and Mary Stevens Neuroimaging and Informatics Institute Karen D. Lincoln, PhD, MSW, MA, FGSA, of the USC ... Read More »
The list recognizes "the true pioneers in their fields over the last decade, demonstrated by the production of multiple highly cited papers that rank in the top 1% by citations."
Researchers at Keck School of Medicine of USC identify a novel target related to the blood-brain barrier and a potential therapy that offers hope for slowing progression of ... Read More »
The study, titled “Finance, Cognition, and Default Network in Aging (FCDNA)” will follow 180 older adults for three years.
Paul Aisen, MD, director of the Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine at USC, will oversee a study of a new drug in ... Read More »
